1. Home
  2. DG vs GH Comparison

DG vs GH Comparison

Compare DG & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dollar General Corporation

DG

Dollar General Corporation

SELL

Current Price

$130.49

Market Cap

27.5B

ML Signal

SELL

Logo Guardant Health Inc.

GH

Guardant Health Inc.

SELL

Current Price

$163.18

Market Cap

22.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DG
GH
Founded
1939
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5B
22.9B
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
DG
GH
Price
$130.49
$163.18
Analyst Decision
Buy
Strong Buy
Analyst Count
31
26
Target Price
$142.83
★ $201.64
AVG Volume (30 Days)
1.4M
★ 1.9M
Earning Date
12-03-2026
11-05-2026
Dividend Yield
★ 1.89%
N/A
EPS Growth
★ 34.05
6.74
EPS
★ 4.49
N/A
Revenue
★ $42,724,369,000.00
$982,021,000.00
Revenue This Year
$4.27
$38.25
Revenue Next Year
$4.05
$35.37
P/E Ratio
$27.84
★ N/A
Revenue Growth
5.20
★ 32.88
52 Week Low
$95.11
$64.00
52 Week High
$158.23
$191.05

Technical Indicators

Market Signals
Indicator
DG
GH
Relative Strength Index (RSI) 61.91 42.58
Support Level $115.67 $153.88
Resistance Level $132.00 $173.94
Average True Range (ATR) 3.66 7.44
MACD 0.88 -2.28
Stochastic Oscillator 99.15 14.74

Price Performance

Historical Comparison
DG
GH

About DG Dollar General Corporation

Since its beginning in 1939, Dollar General has grown to become the largest dollar store operator in the United States, with more than 20,000 small-box discount stores across 48 states. The firm generated over $42 billion in fiscal 2025 sales. The retailer maintains a heavy concentration of stores in rural and low-income markets underserved by big-box retailers. It's 11,000 stock-keeping units, including 2,000 priced at $1 or less, span consumables (82% of sales), seasonal items (10%), home products (5%), and apparel (3%). More than 20% of sales are derived from private label.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: